Search

Stephen W Mamber

from Alexandria, VA
Age ~70
Get Report
Also known as:
Stephen S Mamber, Steve Mamber, Solomon Mamber, Susan E Eicher, Susan E Ficher, Susan Eicher Mamber, Mamber Solomon
Related to:
Samuel Mamber, 26Susan E Mamber, 67
Connected to:
Alim Y Mambetov, 41Dick W Mambo, 37Frederick M Mambo, 45Andrea Mambretti, 35Francesco Mambrini, 45Lawrence J Mambrino, 64Alicia Mambro, 32Maureen Mambro, 53Vincent Mambro, 89Rogelio Mambru, 98

Stephen Mamber Phones & Addresses

  • Alexandria, VA
  • 4313 Roberts Ave, Annandale, VA 22003
  • 28 Lafayette St, Pawtucket, RI 02860
  • 67 Apple Hl, Wethersfield, CT 06109
  • West Hartford, CT
  • Cape Coral, FL
  • Kingston, RI
  • Ann Arbor, MI

Business Records

Name / Title
Company / Classification
Phones & Addresses
Stephen Mamber
Vice-President
Beech Tree Labs, Inc
Research And Development · Commercial Physical Research
117 Chapman St, Providence, RI 02905
220 W Exchange St, Providence, RI 02903
(401) 273-2060

Publications

Us Patents

Tyrissamycin Antibiotic

View page
US Patent:
7256024, Aug 14, 2007
Filed:
Nov 18, 2004
Appl. No.:
10/891888
Inventors:
Jingfang Q. Cutrone - Wallingford CT, US
Lyndon M. Foster - Oceanside CA, US
Kimberly D. Krampitz - Southington CT, US
Stephen W. Mamber - Pawtucket RI, US
Grace A. McClure - Northford CT, US
Todd C. Peterson - Coronado CA, US
Lisa C. Rupar - Woodbury CT, US
Katie A. Thompson - Milford IA, US
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
International Classification:
C12P 7/62
A61K 35/66
A61K 35/74
US Classification:
435135, 424115, 424116, 560130, 4352535, 435108, 435170, 435 41
Abstract:
A novel tyrosyl diester antibiotic is obtained from fermentation of a recombinant strain of designated WD 15684 (ATCC-202143). The new antibiotic, designated tyrissamycin, exhibits antibacterial activity, particularly against gram-positive bacteria.

Cytotoxic Xanthone Compounds

View page
US Patent:
8263644, Sep 11, 2012
Filed:
Sep 11, 2008
Appl. No.:
12/677926
Inventors:
John E. Leet - Madison CT, US
Craig R. Fairchild - Yardley PA, US
Stephen W. Mamber - Annandale VA, US
Xiaohong Liu - Wallingford CT, US
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
International Classification:
A01N 43/16
A61K 31/35
C07D 311/78
C07D 311/94
C07D 311/82
US Classification:
514453, 514454, 549383, 549392
Abstract:
The present invention relates to xanthone compounds isolated from the plant Hochr. (Clusiaceae), a Madagascar plant, which are potent cytotoxic agents.

Tyrissamycin Antibiotic

View page
US Patent:
20020119145, Aug 29, 2002
Filed:
Oct 1, 2001
Appl. No.:
09/968598
Inventors:
Jingfang Cutrone - Wallingford CT, US
Lyndon Foster - Carlsbad CA, US
Kimberly Krampitz - Southington CT, US
Stephen Mamber - Wethersfield CT, US
Grace McClure - Northford CT, US
Todd Peterson - Coronado CA, US
Lisa Rupar - Woodbury CT, US
Katie Thompson - Milford IA, US
International Classification:
A61K035/00
C12N001/20
US Classification:
424/115000, 435/253300
Abstract:
A novel tyrosyl diester antibiotic is obtained from fermentation of a recombinant strain of designated WD 15684 (ATCC-202143). The new antibiotic, designated tyrissamycin, exhibits antibacterial activity, particularly against gram-positive bacteria.

Tyrissamycin Antibiotic

View page
US Patent:
6328961, Dec 11, 2001
Filed:
Aug 20, 1999
Appl. No.:
9/378309
Inventors:
Jingfang Cutrone - Wallingford CT
Lyndon M. Foster - Carlsbad CA
Kimberly Krampitz - Southington CT
Stephen W. Mamber - Wethersfield CT
Grace McClure - Northford CT
Todd C. Peterson - Coronado CA
Lisa C. Rupar - Woodbury CT
Katie A. Thompson - Milford IA
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
International Classification:
A61K 3566
US Classification:
424115
Abstract:
A novel tyrosyl diester antibiotic is obtained from fermentation of a recombinant strain of Streptomyces lividans designated Streptomyces lividans WD 15684 (ATCC-202143). The new antibiotic, designated tyrissamycin, exhibits antibacterial activity, particularly against gram-positive bacteria.

Antitumor Antibiotic Bms-199687

View page
US Patent:
59196718, Jul 6, 1999
Filed:
Feb 13, 1998
Appl. No.:
9/023779
Inventors:
Mitsuaki Tsunakawa - Kanagawa, JP
Li-Ping Chang - New Britain CT
Stephen W. Mamber - Wethersfield CT
Isia Bursuker - Cheshire CT
Robert Hugill - Middletown CT
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
International Classification:
C12P 1716
C12N 120
US Classification:
435118
Abstract:
The present invention relates to the novel antitumor antibiotic designated BMS-199687 and to its preparation. The compound is obtained by culturing a new strain of Actinomadura ferruginea. BMS-199687 demonstrates antitumor activity in standard antitumor animal model systems.

Antitumor Antibiotic Bms-199687

View page
US Patent:
58114408, Sep 22, 1998
Filed:
Apr 2, 1997
Appl. No.:
8/838223
Inventors:
Mitsuaki Tsunakawa - Kanagawa, JP
Li-Ping Chang - New Britain CT
Stephen W. Mamber - Wethersfield CT
Isia Bursuker - Cheshire CT
Robert Hugill - Middletown CT
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
International Classification:
A01N 4376
C12P 1716
C07D26722
US Classification:
514374
Abstract:
The present invention relates to the novel antitumor antibiotic designated BMS-199687 and to its preparation. The compound is obtained by culturing a new strain of Actinomadura ferruginea. BMS-199687 demonstrates antitumor activity in standard antitumor animal model systems.

Isbn (Books And Publications)

Cinema Verite in America:Studies in Uncontrolled Documentary: Studies in Uncontrolled Documentary

View page
Author

Stephen Mamber

ISBN #

0262130920

Control profile
Stephen W Mamber from Alexandria, VA, age ~70 Get Report